• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Digirad shares drop on Q3 earnings release

Digirad shares drop on Q3 earnings release

November 2, 2018 By Fink Densford

Digirad

Shares in Digirad Corp. (NSDQ:DRAD) have fallen today after the company posted third quarter earnings that saw sales shrinking slightly.

The Suwanee, Ga.-based company posted losses of $1.4 million, or 7¢ per share, on sales of $25.7 million for the three months ended September 30, seeing losses shrink 84% while sales shrunk 0.3% compared with the same period during the previous year.

Sales for the quarter narrowly topped the $24.9 million consensus on Wall Street.

“Overall, our business had some challenges during the quarter, which we expect to be temporary in nature. Despite these challenges, we were still able to keep revenue flat on a year over year basis, with diagnostic services revenue outperforming over the prior year. Our Digirad imaging solutions unit within diagnostic services suffered weather related issues due to storms in the southeast but still managed to outperform the prior year quarter by 6%. Mobile Healthcare’s performance in the quarter was impacted by higher than normal equipment and trailer maintenance costs, however interim rental revenue continued to outperform increasing by 24% over the prior year’s quarter. Camera sales again impacted our revenue generation in diagnostic imaging, but a strong September bodes well for a good finish to the year as budgets for hospital systems’ capital expenditures are being funded,” prez & CEO Matt Molchan said in a prepared statement.

The company reaffirmed its financial guidance for the full year, expecting to see sales from continuing operations of between $100 million and $105 million. Digirad lowered its non-GAAP adjusted EBITDA from between $8.5 million and $9.5 million to approximately $7 million.

Shares in the company have fallen 6% today, at $1.25 as of 12:30 p.m. EDT.

In September, Digirad announced plans to convert into a diversified holding company. In its earnings release, the company said that the plan is on track, nd that it expects to close next spring.

Digirad said that it as part of the transition, it is eliminating dividends so that it can launch a share buyback plan “given the attractive valuation of the company’s current stock price.” The company said it plans to purchase up to 2 million shares of its common stock, representing 10% of the outstanding shares.

“Our mission is to grow and maximize value per share over the long-term, and we believe opportunistic share repurchases will better achieve this goal than continuing to pay dividends given our current stock price,” said chair Jeff Eberwein said in a press release.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Digirad Corp.

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy